Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, By Form, By Product Type, By Geography

Description

Cytotoxic Drugs Contract Manufacturing Market is estimated to be valued at USD 12,606.5 Mn in 2026 and is expected to reach USD 23,157.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 12,606.5 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.10%	2033 Value Projection:	USD 23,157.5 Mn

Cytotoxic drugs contract manufacturing market has grown significantly over the last decade. Increasing incidence of cancer and increasing adoption of various growth strategies such as expansion, collaborations, and acquisitions by the key players are expected to boost market growth over the forecast period. Pharmaceutical and biotechnological companies are involved in research and development of cytotoxic drugs and high potency active pharmaceutical ingredients (HPAPIs), and in the manufacture of drugs in-house or outsource the production to other manufacturers.

Market Dynamics

Rising incidence of cancer is expected to propel the market growth over the forecast period. For instance, according to an American Cancer Society estimations, 2017, 1,688,780 people were estimated to be diagnosed with cancer and 600,920 cancer deaths were reported in the U.S.

Increasing product approval for the treatment of cancer is expected to boost growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in October 2018, Catalent Pharma Solutions received the approval of U.S. Food and Drug Administration (FDA) for Verastem Oncology's COPIKTRA (duvelisib) capsules.

Furthermore, rising adoption of contract manufacturing services by the pharmaceutical companies is expected to drive growth of the global cytotoxic drugs contract manufacturing market over the forecast period. For instance, in September 2018, GB Sciences, Inc. selected Catalent Pharma Solutions to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences' proprietary active pharmaceutical ingredients (APIs) for its Parkinson's disease therapies.

Key features of the study

This report provides in-depth analysis of the cytotoxic drugs contract manufacturing market and provides market size (USD Mn) and compound annual growth rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global cytotoxic drugs contract manufacturing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as part of this study include Lonza Group, Piramal Group, Evonik Industries AG, Novasep Holding SAS, Merck KGaA (SAFC Pharma), Baxter Biopharma Solutions, AbbVie Contract Manufacturing, Cambrex Corporation, BSP Pharmaceuticals S.p.A., CordenPharma International, Catalent, Inc., Albany Molecular Research Inc., Evotec, WuXi AppTec Co., Ltd., Pierre Fabre Laboratories, and Dishman Group
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding their future product launches, technology upgradation, market expansion, and marketing tactics
The global cytotoxic drugs contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the cytotoxic drugs contract manufacturing market

Market Segmentation

Production Scale Insights (Revenue, USD Mn, 2026 - 2033)
- Industrial scale
- Pilot Scale
- Laboratory Scale
Form Insights (Revenue, USD Mn, 2026 - 2033)
- Liquid
- Solid
Product Type Insights (Revenue, USD Mn, 2026 - 2033)
- Oral
- Intravenous
Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Lonza Group
- Piramal Group
- Evonik Industries AG
- Novasep Holding SAS
- Merck KGaA (SAFC Pharma)
- Baxter Biopharma Solutions
- AbbVie Contract Manufacturing
- Cambrex Corporation
- BSP Pharmaceuticals S.p.A.
- CordenPharma Internatisonal
- Catalent, Inc.
- Albany Molecular Research Inc.
- Evotec
- WuXi AppTec Co., Ltd.
- Pierre Fabre Laboratories
- Dishman Group

Product Code: CMI3175

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Production Scale
- Market Snippet, By Form
- Market Snippet, By Product Type
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Epidemiology
Market Trends
Product Launch
Regulatory Scenario
PEST Analysis
Merger and Acquisition Scenario
Technological Advancements

4. Global Cytotoxic Drugs Contract Manufacturing Market, By Production Scale, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Industrial scale
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Pilot Scale
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Laboratory Scale
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Cytotoxic Drugs Contract Manufacturing Market, By Form, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Liquid
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Solid
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Cytotoxic Drugs Contract Manufacturing Market, By Product Type, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oral
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Intravenous
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

7. Global Cytotoxic Drugs Contract Manufacturing Market, By Region, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By Production Scale, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Form, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - South Africa
  - Central Africa
  - North Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
- Lonza Group
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Piramal Group
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Evonik Industries AG
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Novasep Holding SAS
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Merck KGaA (SAFC Pharma)
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Baxter Biopharma Solutions
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- AbbVie Contract Manufacturing
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Cambrex Corporation
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- CordenPharma International
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- BSP Pharmaceuticals S.p.A.
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Catalent, Inc.
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Albany Molecular Research Inc. (AMRI)
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Evotec
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- WuXi AppTec Co., Ltd.
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Pierre Fabre Laboratories
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Dishman Group
  - Company Overview
  - Form Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
  - Analyst Views

9. Section

References
Research Methodology
About Us and Sales Contact